EXACT Therapeutics Feed

	Est. tid*
2025-09-10	21:20	Kvartalsrapport 2025-Q2
2025-06-16	N/A	X-dag ordinarie utdelning EXTX 0.00 NOK
2025-06-13	N/A	Årsstämma
2025-04-09	-	Bokslutskommuniké 2024
2024-12-17	-	Extra Bolagsstämma 2024
2024-09-30	-	Kvartalsrapport 2024-Q2
2024-06-28	-	Årsstämma
2024-06-10	-	X-dag ordinarie utdelning EXTX 0.00 NOK
2024-04-18	-	Bokslutskommuniké 2023
2023-09-28	-	Kvartalsrapport 2023-Q2
2023-06-12	-	X-dag ordinarie utdelning EXTX 0.00 NOK
2023-06-09	-	Årsstämma
2023-04-21	-	Bokslutskommuniké 2022
2022-09-22	-	Kvartalsrapport 2022-Q2
2022-06-09	-	X-dag ordinarie utdelning EXTX 0.00 NOK
2022-06-08	-	Årsstämma
2022-04-27	-	Bokslutskommuniké 2021
2021-08-25	-	Kvartalsrapport 2021-Q2
2021-06-01	-	Årsstämma
2021-05-14	-	X-dag ordinarie utdelning EXTX 0.00 NOK
2021-04-29	-	Bokslutskommuniké 2020
2020-07-27	-	Split EXTX 1:250
2020-07-24	-	Extra Bolagsstämma 2020

Land	Norge
Lista	Euronext Growth Oslo
Sektor	Hälsovård
Industri	Bioteknik

2025-05-07 10:47:40 EXTX: EXACT Therapeutics announces grant of key patent in Japan 2,80 NOK | -6,67%

2025-04-09 21:17:44 EXACT Therapeutics - 2024 Annual Report

2025-01-28 08:00:00 EXTX: EXACT Therapeutics and Cordance Medical Announce Early Encouraging Data in Brain Cancer Mice Model 3,50 NOK | +8,70%

2025-01-07 11:58:03 EXTX: Financial calendar 3,40 NOK | -1,73%

2024-12-24 12:52:50 EXACT Therapeutics AS: Share capital increase registered

2024-12-19 15:37:40 EXACT Therapeutics AS: Primary insider notification 3,58 NOK | -7,25%

2024-12-19 09:01:22 EXTX: EXACT Therapeutics Expands its Board of Directors following the EGM 3,58 NOK | -7,25%

2024-12-18 11:36:22 EXACT Therapeutics AS: Cancellation of subsequent offering 3,86 NOK | +14,88%

2024-12-17 12:00:00 EXACT Therapeutics AS: Minutes from the extraordinary general meeting 3,36 NOK | -4,55%

2024-12-16 08:00:00 EXTX: EXACT Therapeutics Announces FDA Clearance of IND for ENACT, a Phase 2 Trial in Pancreatic Cancer 3,52 NOK | -2,22%

2024-12-11 18:47:10 EXACT Therapeutics AS: Primary insider notification 3,80 NOK | +0,53%

2024-12-11 11:44:11 EXACT Therapeutics AS: Share capital increase registered 3,78 NOK | 0,00%

2024-12-03 14:23:34 EXACT Therapeutics AS: Notice of extraordinary general meeting 4,00 NOK | -33,33%

2024-12-03 08:21:55 EXTX: EXACT Therapeutics to host virtual company presentation on December 4, 2024 following the announcement of completion of private placement 4,00 NOK | -33,33%

2024-12-03 00:12:26 EXACT Therapeutics AS: Key information regarding potential subsequent offering

2024-12-03 00:08:39 EXACT Therapeutics AS: Private placement successfully placed

2024-12-02 16:38:36 EXTX: EXACT Therapeutics Receives Investment from GE HealthCare to Advance Therapeutic Ultrasound in Pancreatic Cancer using ACT® 4,00 NOK | -33,33%

2024-12-02 16:30:00 EXACT Therapeutics AS: Contemplated Private Placement 4,00 NOK | -33,33%

2024-10-08 10:04:14 EXTX: EXACT Therapeutics initiates preclinical immunotherapy collaboration with Agenus Inc. 5,75 NOK | 0,00%

2024-10-02 08:30:00 EXTX: EXACT Therapeutics to Present at the bi-annual Contrast Media Research (CMR) Symposium 2024

2024-09-30 08:00:00 EXTX: EXACT Therapeutics announces first half 2024 interim results 5,75 NOK | 0,00%

2024-09-25 09:00:23 EXTX: EXACT Therapeutics announces grant of immunotherapy patent 5,20 NOK | +4,00%

2024-09-18 20:30:50 EXTX: EXACT Therapeutics to Present at the Annual International Symposium on Therapeutic Ultrasound (ISTU 2024) 5,00 NOK | -3,85%

2024-09-13 15:18:52 EXTX: Financial calendar

2024-08-06 18:33:13 EXACT Therapeutics Company update: Full focus on Phase 2 pancreatic cancer trial 6,55 NOK | 0,00%

2024-06-28 11:47:40 EXTX: EXACT Therapeutics minutes from Annual General Meeting June 28, 2024 7,40 NOK | 0,00%

2024-06-14 09:00:00 EXACT Therapeutics AS - Notice of Annual General Meeting 2024 7,40 NOK | -8,64%

2024-05-23 09:23:49 EXTX: Financial calendar 7,10 NOK | 0,00%

2024-04-18 20:46:28 EXTX: EXACT Therapeutics Annual report 2023 7,00 NOK | 0,00%

2024-04-10 08:57:56 EXTX: Additional promising clinical data from EXACT Therapeutics' ongoing ACTIVATE study presented at AACR Annual Meeting 6,00 NOK | +0,84%

2024-03-06 21:05:25 EXTX: EXACT Therapeutics to Present at 2024 American Association for Cancer Research (AACR) Annual Meeting 9,95 NOK | 0,00%

2024-01-22 14:09:59 EXTX: Financial calendar 12,00 NOK | 0,00%

2023-12-20 11:41:02 EXACT Therapeutics AS - Share capital increase registered. Correction. 12,00 NOK | -4,00%

2023-12-20 10:43:38 EXACT Therapeutics AS - Share capital increase registered 12,00 NOK | -4,00%

2023-12-14 09:45:00 EXTX: EXACT Therapeutics presenting at DNB Nordic Healthcare conference December 14 12,50 NOK | 0,00%

2023-12-01 08:46:06 EXACT Therapeutics AS: Primary insider notices 12,50 NOK | +0,81%

2023-11-30 22:30:06 EXACT Therapeutics AS: Private placement successfully placed 12,50 NOK | +0,81%

2023-11-30 16:30:00 EXACT Therapeutics AS: Contemplated Private Placement 12,50 NOK | +0,81%

2023-10-31 10:48:34 EXTX: EXACT Therapeutics receives regulatory approval to start recruitment of patients at Oslo University hospital 12,70 NOK | -2,31%

2023-10-16 16:35:42 EXACT Therapeutics AS - Issuance of share options 15,20 NOK | 0,00%

2023-10-12 08:49:47 EXTX: EXACT Therapeutics CEO Dr Per Walday to participate in international Drug Delivery panel 14,00 NOK | 0,00%

2023-09-28 08:00:00 EXTX: EXACT Therapeutics announces first half 2023 interim results 15,40 NOK | 0,00%

2023-09-27 14:55:00 EXTX: EXACT Therapeutics announces appointment of Caspar Foghsgaard as SVP Commercial & Business Development 15,40 NOK | -9,41%

2023-09-26 08:30:00 EXTX: EXACT Therapeutics announces positive clinical results from the ACTIVATE Phase I dose escalation 17,00 NOK | +13,33%

2023-09-19 08:41:44 EXTX: Invitation to first half results 2023 presentation of EXACT Therapeutics AS 15,00 NOK | -14,29%

2023-09-13 09:16:43 EXTX: Financial calendar 15,90 NOK | +16,91%

2023-09-06 09:48:11 EXTX: EXACT Therapeutics and Cordance Medical Announce Strategic Partnership to Revolutionize Drug Delivery to the Brain 13,00 NOK | +18,18%

2023-08-07 09:57:11 EXTX: EXACT Therapeutics completed the dose escalation part of ACTIVATE study 12,00 NOK | +8,11%

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

EXACT Therapeutics

Kalender

Beskrivning

EXACT Therapeutics

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden